Comparison of pulsed actinomycin D versus 5‐day methotrexate…
Established
47
Citations28
Refs2011
Year
Search Works
Work Details
- DOI 10.1016/j.ijgo.2011.08.003
- PMID https://pubmed.ncbi.nlm.nih.gov/21996593
- OpenAlex ID W2111046733
- Type Article
- Language EN
- Published 11 Oct 2011
- Volume 116 (1)
- Pages 39–42
- Source International Journal of Gynecology & Ob…
- Publisher Elsevier BV
- FWCI 2.51
- Countries 1
- Institutions 1
- Added 24 Jun 2016
- Updated 31 Oct 2026
External Links
MENU
0
Comparison of pulsed actinomycin D versus 5‐day methotrexate for the treatment of low‐risk gestational trophoblastic disease
Article 2011 EN
OBJECTIVE: To determine the effectiveness of 2 standard chemotherapy regimens for low-risk gestational trophoblastic disease according to the International Federation of Gynecology and Obstetrics (FIGO) staging system. METHODS: From 2008 until 2010, 75 women with low-risk gestational trophoblastic disease received either pulsed actinomycin D (n=50) or 5-day methotrexate (n=25). The primary remissi…
47
Citations
28
References
5
Authors
2.51
FWCI
Citations by Year
Last 15 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
5 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Azamsadat Mousavi | Tehran University of Medical S… (IR) | — |
| 2 | Fatemeh Cheraghi Corresponding | Tehran University of Medical S… (IR) | — |
| 3 | Fariba Yarandi | Tehran University of Medical S… (IR) | |
| 4 | Mitra Modares Gilani | Tehran University of Medical S… (IR) | |
| 5 | Hadi Shojaei | Tehran University of Medical S… (IR) | — |
Related Works
10Data: OpenAlex